drugset / Trial / NCT00180947

Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse

NCT00180947 ↗

Phase 2 Unknown 210 enrolled Gustave Roussy, Cancer Campus, Grand Paris
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This is a phase II study to determine the antitumor activity of Vinorelbine and Cyclofosfamide association among patients with refractory tumours or in relapse with rhabdomyosarcomas and other soft tissue tumours, Ewing tumours, osteosarcomas, neuroblastomas or medulloblastomas.

Timeline

Start
2003-06
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Vinorelbine Small molecule — —
Subject cyclofosfamide Unknown — —